Checkmate Pharmaceuticals

-$0.14 (-1.94%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell CMPI and other stocks, options, and ETFs commission-free!

About CMPI

Checkmate Pharmaceuticals, Inc. Common Stock, also called Checkmate Pharmaceuticals, is a clinical-stage biotechnology company.

CEO
Barry A. Labinger
Employees
25
Headquarters
Cambridge, Massachusetts
Founded
2015

CMPI Key Statistics

Market Cap
155.66M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
65.95K
High Today
$7.23
Low Today
$6.94
Open Price
$7.23
Volume
95.48K
52 Week High
$23.10
52 Week Low
$5.84

CMPI Earnings

-$7.37
-$4.48
-$1.59
$1.30
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 14, After Hours

You May Also Like

DRIP
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure